Spain and Canada sign R&D (research and development) agreement:
This article was originally published in Clinica
Biotechnology is among the areas of research that will benefit from a co-operation agreement signed between Spain and Canada. The national research councils of both countries - CSIC and NRC, respectively - will jointly develop policies concerning the promotion of technological innovation in a number of fields and a technology transfer programme. The latter will seek to promote the involvement of small and medium-sized enterprises in both countries.
You may also be interested in...
The latest figures from China's National Health Commission show infections of the new Wuhan coronavirus are continuing to pile up, spreading to more cities in the country and abroad as travel for the Lunar New Year festival goes into high gear. Meanwhile, the Chinese government maintains that the situation is “preventable and controllable.”
CDER Office of New Drugs changes its organization including establishing Office of Nonprescription Drugs and splitting the office into Division of Nonprescription Drug Products I and DNDP II. A Division of Regulatory Operations for Nonprescription Drugs will be comprised of regulatory staff from the ONPD divisions and will report to OND’s regulatory office. Non-clinical ONPD staff will report to the office director.